李继中 曾艳 王才会
【摘要】 目的:探究急性缺血性脑卒中生物标志物在预测早期神经功能恶化的临床价值。方法:选择2015-2016年在本院确诊的急性缺血性脑卒中(AIS)患者60例,按照随机数字表法将其分成两组,急性缺血性脑卒中患者合并早期神经功能恶化为治疗组,无早期神经功能恶化的为对照组,检测可疑END患者谷氨酸、γ-氨基丁酸的表达水平。结果:治疗组在END诊断中的敏感性96.67%和特异性93.33%均明显优于对照组的70.00%和73.33%,比较差异有统计学意义(P<0.05);治疗组AIS患者身体健康情况100%明显强于对照组的80.00%,比较差异有统计学意义(P<0.05);治疗组AIS患者的满意度100%明显高于对照组的83.33%,比较差异有统计学意义(P<0.05)。结论:急性缺血性脑卒中生物标志物可使AIS患者早期神经功能恶化得到更早的判断,及时接受治疗,降低疾病的危害性。
【关键词】 生物标志物; 早期神经功能恶化; 急性缺血; 脑卒中
Clinical Value of Biomarkers of Acute Ischemic Stroke in Predicting Early Neurological Deterioration/LI Jizhong,ZENG Yan,WANG Caihui.//Medical Innovation of China,2018,15(13):139-141
【Abstract】 Objective:To explore the clinical value of biomarkers of acute ischemic stroke in predicting early neurological deterioration.Method:A total of 60 cases of acute ischemic stroke (AIS) diagnosed in our Hospital from 2015 to 2016 were selected.According to the random number table method,they were divided into two groups,patients with acute ischemic stroke complicated with early neurologic deterioration as treatment group and with no early neurological deterioration as control group.The expression levels of glutamic acid andγ-aminobutyric acid in patients with suspected END were tested.Result:The sensitivity and specificity of the treatment group in END diagnosis were 96.67% and 93.33%,respectively,which were significantly higher than 70.00% and 73.33% of the control group,the differences were statistically significant(P<0.05).The health status of AIS patients in the treatment group was 100% significantly higher than 80.00% in the control group, the difference was statistically significant(P<0.05).The satisfaction degree of AIS patients in the treatment group was 100% significantly higher than 83.33% in the control group,the difference was statistically significant(P<0.05).Conclusion:The biomarkers of acute ischemic stroke can make early neurological deterioration in AIS patients be judged earlier,timely receive treatment,and reduce the harm of the disease.
【Key words】 Biomarkers; Early neurological deterioration; Acute ischemia; Stroke
First-authors address:Fifth Affiliated Hospital of Zunyi Medical College(Zhuhai),Zhuhai 519000,China
doi:10.3969/j.issn.1674-4985.2018.13.040
早期神經功能恶化(END)是急性缺血性脑卒中比较常见的一种现象,有着很高的致残率和死亡率,是脑梗死患者死亡原因之一[1-3]。END的早期诊断主要依靠患者症状、体征,但发现时已经为时已晚,就像恶性肿瘤已经广泛转移,补救的效果微乎其微,因而,END的早期诊断具有不可替代的医疗意义[4-8]。基于此,本院采用急性缺血性脑卒中生物标志物预测早期神经功能恶化情况,具体预测情况报道如下。
1 资料与方法
1.1 一般资料 选择2015-2016年在本院确诊的AIS患者60例,采用随机数字表法将其分成治疗组和对照组,每组各30例,入组患者均已签署相关知情同意书。其中男29例,女31例,平均年龄(58.37±5.31)岁。纳入标准:所有患者均符合AIS的诊断标准。排除标准:其他脏器损伤的患者,精神疾病的患者,肝肾损伤的患者,器质性疾病患者。经本院伦理委员会批准,所有患者均签署知情同意书。
1.2 方法 要求患者在就诊时留取外周静脉血标本5 mL,用于谷氨酸、r-氨基丁酸的检测,并经影像学检查及临床表现确定有无早期神经功能恶化[1-2],记录其完整的临床资料。……